This site isintended forUS audiences only.
*Fields are required.
REVLIMID® (lenalidomide) is a prescription medicine, used to treat people with multiple myeloma (MM) in combination with the medicine dexamethasone, or as maintenance treatment after autologous hematopoietic stem cell transplantation (a type of stem cell transplant that uses your own stem cells).
REVLIMID should not be used to treat people who have chronic lymphocytic leukemia (CLL) unless they are participants in a controlled clinical trial. It is not known if REVLIMID is safe and effective in children.
Back to top
Before you begin taking REVLIMID, you must read and agree to all of the instructions in the REVLIMID REMS® program. Before prescribing REVLIMID, your healthcare provider will explain the REVLIMID REMS program to you and have you sign the Patient-Physician Agreement Form.
REVLIMID may cause serious side effects, including:
Call your healthcare provider or get medical help right away if you get any of the following during treatment with REVLIMID:
Before you take REVLIMID, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. REVLIMID and other medicines may affect each other, causing serious side effects. Talk with your healthcare provider before taking any new medicines. Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist.
Take REVLIMID exactly as prescribed and follow all the instructions of the REVLIMID REMS program
REVLIMID can cause serious side effects, including:
The most common side effects of REVLIMID include:
These are not all the possible side effects of REVLIMID. Your healthcare provider may tell you to decrease your dose, temporarily stop or permanently stop taking REVLIMID if you develop certain serious side effects during treatment with REVLIMID. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Please see full Prescribing Information, including Boxed WARNINGS and Medication Guide
TO REPORT SUSPECTED ADVERSE REACTIONS OR EMBRYO-FETAL EXPOSURE: CONTACT CELGENE CORPORATION AT 1-888-423-5436 OR FDA AT 1-800-FDA-1088 OR WWW.FDA.GOV/MEDWATCH.
My Moments, My Support is a new program for people who are taking REVLIMID for multiple myeloma or for people who want more information about REVLIMID.
Join now to receive your REVLIMID Treatment Overview Brochure.
If you or a loved one are currently on REVLIMID and would like a Patient Starter Kit, please check the box to request a Kit when you enroll.
When you enroll in Celgene Patient Support®, you and your family can count on free, personal help with:
• Finding financial help to pay for REVLIMID
• Understanding your insurance plan
• Locating help with travel costs to and from your doctor's office
Celgene Patient Support
(M-F, 8 am-7 pm ET)
Receive e-mails featuring content about what to expect with REVLIMID.
Learn more about multiple myeloma.
REVLIMID® (lenalidomide) is a prescription medicine, used to treat people with multiple myeloma (MM) in combination with the medicine dexamethasone, or as maintenance
Before you begin taking REVLIMID, you must read and agree to all of the instructions in the REVLIMID REMS® program. Before prescribing REVLIMID,
This website is intended for
US healthcare professionals only.
Complete the form fields below to share this page.
Your e-mail was sent.
Thank you for joining My Moments, My Support.
Thank you for sharing your moment. You will receive an e-mail notification if your moment is selected to be featured on REVLIMID.com.